New insights into insulin resistance in the diabetic heart
Recent discoveries regarding the role of inflammation, mitochondrial dysfunction and endoplasmic reticulum (ER) stress in obesity have advanced our understanding of how insulin resistance develops in peripheral organs. In this review, we examine these findings in relation to the diabetic heart to provide new insights into the mechanism of cardiac insulin resistance (Trends in Endocrinology & Metabolism)
Type 2 Diabetes Affects Brain Health Differentially in Men and Women
These important findings indicate that in addition to the higher rate of traditional medical complication, females with T2DM are more likely to also suffer more brain complication than males (Diabetes/Metabolism Research and Reviews)
Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate
Our findings provide important insights into understanding the pathogenesis of the diabetes-induced changes in prostate as well as identifying potential therapeutic targets for future studies (Nature)
Effect of pharmacist intervention on glycemic control in diabetes
Our findings demonstrate statistically and clinically significant associations between pharmacist intervention and improvement in glycemic control (Diabetes Research and Clinical Practice)
The Care of Diabetic Foot Ulcers
This lecture by Dr. Robert Kirsner will discuss the results of the Consensus Recommendations On Advancing The Standard of Care for Treating Neuropathic Foot Ulcers in Patients with Diabetes (Present PODIATRY)
Prevalence of Type 1 diabetes in Australian children, 2008
AIHW, Australia
Diabetes and poor mental health and wellbeing: an exploratory analysis
Australians with diabetes are significantly more likely than other Australians to have poor mental health and wellbeing (AIHW, Australia)
Short-Term Intensive Therapy in Newly Diagnosed Type 2 Diabetes Partially Restores Both Insulin Sensitivity and ß-Cell Function in Subjects With Long-Term Remission
IT in newly diagnosed type 2 diabetes not only partially restored ß-cell function but also greatly restored insulin sensitivity. Compared with IGT and NGT subjects, ß-cell function was less restored than insulin sensitivity after IT in the remission subjects (Diabetes Care)
Bydureon Receives Marketing Authorization in Europe
Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announce that the European Commission has granted marketing authorization to BYDUREON™ – exenatide 2 mg powder and solvent for prolonged release suspension for injection (Pharma Live)
Zealand Pharma and Boehringer Ingelheim
Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity (Therapeutics Daily)
Glycosmedia is also available as an App: